The EPS projection of Abercrombie & Fitch Company (NYSE:ANF) for quarter ended 2016-10-31 is $0.47. Last week, the projection for EPS was $0.47 against target of $0.47, a month earlier. While 2-months ago, this projection was $0.47 versus forecast of $0.47a quarter months earlier, posting a deviation of 0%.
Abercrombie & Fitch Company (NYSE:ANF) posted that 18 days earlier, the share price was revised 5 times on upside. In addition, negative revisions were 1.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 5. While in last 120 and 90 days, positive revisions were 5, and 5, correspondingly.
The per-share earnings downgrade for Abercrombie & Fitch Company (NYSE:ANF) in the preceding 30 and 120 were 1 and 4. While in 60 and 90 days were 5, and 4, in that order.
Abercrombie & Fitch Company (NYSE:ANF) EPS target was $0.47 for the quarter closed 1. It was based on 15 calls. As on 2016-05-26 the EPS was $-0.59. The change was $-0.09, posting a deviation of -18%. The price projections gave a standard deviation of 0.04.
Quarterly Sales Estimates
Abercrombie & Fitch Company (NYSE:ANF) sales prediction for the fiscal 2017 stands at $1118.395 and the median estimate is at $1124.47. Almost 9 analysts gave sales target.
Among this, the highest sales estimate is $1146.3 while the lowest target is $1054.01 showing standard deviation of 27.955%.
As many as 9 analysts have positive sales targets revision while 9 reduced sales estimates, posting a deviation of 0%.
Last month, 9 experts have positive sales number revision. Also, 9 research groups lowered the sales projections, posting a deviation of -0.368%.
A quarter ago, 9 hiked sales target and 9 reduced sales forecast, posting a deviation of -0.049%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...